Source:http://linkedlifedata.com/resource/pubmed/id/19288025
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-3-16
|
pubmed:abstractText |
We investigated the effects of arginine on the multiplication of herpes simplex virus type 1 (HSV-1) and the potential of arginine as an antiherpetic agent. Arginine suppressed the growth of HSV-1 concentration-dependently. Inhibition of HSV-1 by arginine leveled off at 50-60 mM, although the higher concentration was not suitable as an antiviral agent due to cytotoxicity. 'Time of addition' experiments revealed that arginine was particularly effective when added within 6 h post-infection (h p.i.), suggesting that the reagent sensitive step is in the early stages of the infection. A one-step growth curve of HSV-1 in the presence of 30 mM arginine revealed that: i) the latent period was significantly extended, ii) the rate of formation of progeny infectious virus decreased and iii) the final yield of progeny virus decreased to 1%. The addition of arginine at 8 h p.i., after the completion of viral DNA replication in the virus multiplication, allowed the normal formation of progeny virus in the subsequent 4 h, confirming that arginine does not directly interfere with the formation of progeny infectious virus. In addition, arginine also inhibits several RNA viruses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1107-3756
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
495-9
|
pubmed:meshHeading |
pubmed-meshheading:19288025-Animals,
pubmed-meshheading:19288025-Antiviral Agents,
pubmed-meshheading:19288025-Arginine,
pubmed-meshheading:19288025-Cell Line,
pubmed-meshheading:19288025-Cell Line, Tumor,
pubmed-meshheading:19288025-Cercopithecus aethiops,
pubmed-meshheading:19288025-Dose-Response Relationship, Drug,
pubmed-meshheading:19288025-Herpesvirus 1, Human,
pubmed-meshheading:19288025-Humans,
pubmed-meshheading:19288025-Time Factors,
pubmed-meshheading:19288025-Vero Cells,
pubmed-meshheading:19288025-Virus Replication
|
pubmed:year |
2009
|
pubmed:articleTitle |
Antiviral effect of arginine against herpes simplex virus type 1.
|
pubmed:affiliation |
Department of Ophthalmology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan. naito@clin.med.tokushima-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|